Sugimoto, Kayo <br/><br/>
Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2.  [electronic resource] 

 -  Digestive diseases (Basel, Switzerland)   
 - 627-631 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1421-9875 
<br/><br/><label>Standard No.: </label>10.1159/000448823  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Drug Carriers<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hemoglobins--analysis<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferons--therapeutic use<br/>Liver Cirrhosis--drug therapy<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols<br/>Pyrophosphatases--genetics<br/>Ribavirin--administration & dosage<br/>Safety<br/>Sofosbuvir--administration & dosage<br/>Treatment Outcome<br/>Inosine Triphosphatase